437 related articles for article (PubMed ID: 26899578)
1. In vitro effect of octenidine dihydrochloride against Trichomonas vaginalis.
Küng E; Pietrzak J; Klaus C; Walochnik J
Int J Antimicrob Agents; 2016 Mar; 47(3):232-4. PubMed ID: 26899578
[TBL] [Abstract][Full Text] [Related]
2. Pentamycin shows high efficacy against Trichomonas vaginalis.
Kranzler M; Syrowatka M; Leitsch D; Winnips C; Walochnik J
Int J Antimicrob Agents; 2015 Apr; 45(4):434-7. PubMed ID: 25703311
[TBL] [Abstract][Full Text] [Related]
3. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population.
Krashin JW; Koumans EH; Bradshaw-Sydnor AC; Braxton JR; Evan Secor W; Sawyer MK; Markowitz LE
Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623
[TBL] [Abstract][Full Text] [Related]
4. Drug library screening against metronidazole-sensitive and metronidazole-resistant Trichomonas vaginalis isolates.
Goodhew EB; Secor WE
Sex Transm Infect; 2013 Sep; 89(6):479-84. PubMed ID: 23794105
[TBL] [Abstract][Full Text] [Related]
5. Mycoplasma hominis infection of Trichomonas vaginalis is not associated with metronidazole-resistant trichomoniasis in clinical isolates from the United States.
Butler SE; Augostini P; Secor WE
Parasitol Res; 2010 Sep; 107(4):1023-7. PubMed ID: 20652315
[TBL] [Abstract][Full Text] [Related]
6. [Investigation of in vitro metronidazole resistance in the clinical isolates of Trichomonas vaginalis].
Ertabaklar H; Yaman Karadam S; Malatyalı E; Ertuğ S
Mikrobiyol Bul; 2016 Oct; 50(4):552-558. PubMed ID: 28124960
[TBL] [Abstract][Full Text] [Related]
7. The Role of Iron Status in the Early Progression of Metronidazole Resistance in Trichomonas vaginalis Under Microaerophilic Conditions.
Argáez-Correa W; Alvarez-Sánchez ME; Arana-Argáez VE; Ramírez-Camacho MA; Novelo-Castilla JS; Coral-Martínez TI; Torres-Romero JC
J Eukaryot Microbiol; 2019 Mar; 66(2):309-315. PubMed ID: 30047563
[TBL] [Abstract][Full Text] [Related]
8. Chlorinated metronidazole as a promising alternative for treating trichomoniasis.
Chacon MO; Fonseca THS; Oliveira SBV; Alacoque MA; Franco LL; Tagliati CA; Cassali GD; Campos-Mota GP; Alves RJ; Capettini LSA; Gomes MA
Parasitol Res; 2018 May; 117(5):1333-1340. PubMed ID: 29502297
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of hexadecylphosphocholine (miltefosine) against metronidazole-resistant and -susceptible strains of Trichomonas vaginalis.
Blaha C; Duchêne M; Aspöck H; Walochnik J
J Antimicrob Chemother; 2006 Feb; 57(2):273-8. PubMed ID: 16344287
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the in vitro activity of ceragenins against Trichomonas vaginalis.
Polat ZA; Cetin A; Savage PB
Acta Parasitol; 2016 Mar; 61(2):376-81. PubMed ID: 27078662
[TBL] [Abstract][Full Text] [Related]
11. Metronidazole resistance in Trichomonas vaginalis from highland women in Papua New Guinea.
Upcroft JA; Dunn LA; Wal T; Tabrizi S; Delgadillo-Correa MG; Johnson PJ; Garland S; Siba P; Upcroft P
Sex Health; 2009 Dec; 6(4):334-8. PubMed ID: 19917203
[TBL] [Abstract][Full Text] [Related]
12. The presence of dsRNA virus in Trichomonas vaginalis isolates from symptomatic and asymptomatic Indian women and its correlation with in vitro metronidazole sensitivity.
Malla N; Kaul P; Sehgal R; Gupta I
Indian J Med Microbiol; 2011; 29(2):152-7. PubMed ID: 21654110
[TBL] [Abstract][Full Text] [Related]
13. Novel metronidazole-chalcone conjugates with potential to counter drug resistance in Trichomonas vaginalis.
Anthwal A; Rajesh UC; Rawat MS; Kushwaha B; Maikhuri JP; Sharma VL; Gupta G; Rawat DS
Eur J Med Chem; 2014 May; 79():89-94. PubMed ID: 24727243
[TBL] [Abstract][Full Text] [Related]
14. Hydrogenosomes of laboratory-induced metronidazole-resistant Trichomonas vaginalis lines are downsized while those from clinically metronidazole-resistant isolates are not.
Wright JM; Webb RI; O'Donoghue P; Upcroft P; Upcroft JA
J Eukaryot Microbiol; 2010; 57(2):171-6. PubMed ID: 20015182
[TBL] [Abstract][Full Text] [Related]
15. [In vitro susceptibility of Trichomonas vaginalis to metronidazole, ornidazole and proton pump inhibitors pantoprazole and esomeprazole].
Aksoy Gökmen A; Girginkardeşler N; Kilimcioğlu AA; Şirin MC; Özbilgin A
Mikrobiyol Bul; 2016 Jan; 50(1):133-9. PubMed ID: 27058337
[TBL] [Abstract][Full Text] [Related]
16. Antiparasitic activity of furanyl N-acylhydrazone derivatives against Trichomonas vaginalis: in vitro and in silico analyses.
Alves MSD; das Neves RN; Sena-Lopes Â; Domingues M; Casaril AM; Segatto NV; Nogueira TCM; de Souza MVN; Savegnago L; Seixas FK; Collares T; Borsuk S
Parasit Vectors; 2020 Feb; 13(1):59. PubMed ID: 32046788
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the effect of some medicinal plants on cultured Trichomonas Vaginalis.
Selim MA; Fawzy EM; Abd El-Rahman EM; Abdel Hady RS; Badr MS; Abdel Hamed EF
J Infect Dev Ctries; 2020 Jul; 14(7):793-799. PubMed ID: 32794472
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of netropsin dihydrochloride against the viability, cytopathogenicity and hemolytic activity of Trichomonas vaginalis clinical isolates.
Abou Gamra MM; Kamel HH; Ezz Eldin HM; Taha Zahran FM
J Infect Chemother; 2019 Dec; 25(12):955-964. PubMed ID: 31189504
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic aspects of trichomoniasis].
Vukićević J; Jankicević J
Srp Arh Celok Lek; 2003; 131(3-4):156-61. PubMed ID: 14608880
[TBL] [Abstract][Full Text] [Related]
20. The genetic diversity of metronidazole susceptibility in Trichomonas vaginalis clinical isolates in an Egyptian population.
Abdel-Magied AA; El-Kholya EI; Abou El-Khair SM; Abdelmegeed ES; Hamoudaa MM; Mohamed SA; El-Tantawy NL
Parasitol Res; 2017 Nov; 116(11):3125-3130. PubMed ID: 28956167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]